NATURES SUNSHINE PRODUCTS INC
NATR · XNASCIK 275053fmd_1P8AEDBBA3HYRRFJJAGTBQDJ1JManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 341 | 342 | 365 | 362 | 385 | 444 | 422 | 445 | 454 | 480 |
| Cost of revenue | 91 | 91 | 96 | 94 | 101 | 115 | 122 | 124 | 130 | 132 |
| Gross profit | 250 | 251 | 269 | 268 | 284 | 329 | 300 | 321 | 325 | 348 |
| Realized investment gains (losses) | 0 | 0 | (0) | 0 | 0 | 0 | (0) | 0 | 0 | 0 |
| Research and development | 3 | 3 | 3 | 2 | 2 | 1 | 2 | 2 | 2 | 2 |
| Selling, general and administrative | 120 | 130 | 138 | 129 | 131 | 154 | 153 | 167 | 164 | 178 |
| Total operating expenses | – | – | – | – | – | – | – | – | – | – |
| Operating income | 10 | 1 | 5 | 16 | 21 | 35 | 16 | 19 | 20 | 25 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest and investment income | – | – | – | – | – | – | – | – | – | – |
| Other non-operating income (expense) | (1) | 2 | (2) | (0) | 1 | (3) | (1) | 1 | (2) | 5 |
| Income before taxes | 9 | 3 | 3 | 16 | 23 | 32 | 15 | 20 | 18 | 30 |
| Income tax expense | 9 | 17 | 4 | 9 | (0) | 2 | 15 | 4 | 11 | 9 |
| Net income from continuing operations | 1 | (14) | (1) | 7 | 23 | 30 | 1 | 16 | 8 | 20 |
| Net income | 1 | (14) | (1) | 7 | 23 | 30 | (0) | 15 | 8 | 20 |
| Net income to common shareholders | 2 | (13) | (1) | 7 | 21 | 29 | (0) | 15 | 8 | 20 |